CellNovo
closedDiabetes management system.
Launch date
–
Employees
Market cap
-
Enterprise valuation
$110m (Public information from Jul 2015)
Company register number 04349221
Swansea Wales (HQ)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
Revenues | 1.0m | 3.0m | 3.0m | 19.0m |
% growth | - | 200 % | - | 533 % |
EBITDA | (17.0m) | (12.0m) | (13.0m) | (10.0m) |
% EBITDA margin | (1700 %) | (400 %) | (433 %) | (53 %) |
Profit | (17.0m) | (14.0m) | (14.0m) | (12.0m) |
% profit margin | (1700 %) | (467 %) | (467 %) | (63 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Series A | |
£30.0m | Series B | ||
N/A | €32.0m Valuation: €100m | IPO | |
N/A | €5.4m | Post IPO Equity | |
€5.0m | Post IPO Equity | ||
* | €17.5m | Post IPO Equity | |
Total Funding | $39.6m |
Recent News about CellNovo
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.